Valuation : Clover Corporation Limited

Market Cap 148M 106M 90.92M 85.34M 77.94M 147M 10.1B 1.01B 391M 5.1B 398M 389M 16.88B P/E 2026 *
15.2x
P/E 2027 * 11x
Enterprise Value 146M 104M 89.51M 84.01M 76.73M 145M 9.95B 994M 385M 5.02B 392M 383M 16.62B EV / Sales 2026 *
1.55x
EV / Sales 2027 * 1.21x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+1.69%
1 week-0.55%
Current month-5.73%
1 month-3.21%
3 months+7.74%
6 months+21.48%
Current year+14.56%
1 week 0.89
Extreme 0.89
0.98
1 month 0.88
Extreme 0.88
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
6/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.69%-0.55%+56.03%-11.27% 106M
0.00%-9.24%+7.65%+65.95% 12.08B
-2.10%-0.25%-18.36%+382.72% 9.42B
+1.46%-1.62%-22.04%-48.38% 2.45B
+2.88%+1.57%-12.78%-3.23% 1.53B
-0.07%-0.20%+26.04%+74.57% 1.36B
-4.10%-0.48%+34.24%-19.91% 1.3B
+0.28%+0.56%-72.87%-73.38% 1.25B
-0.27%-2.13%-40.60% - 1.12B
-3.74%-7.95%-63.33%-69.41% 932M
Average -0.40%-1.00%-10.60%+33.07% 3.16B
Weighted average by Cap. -0.65%-2.83%-8.37%+137.92%

Financials

2026 *2027 *
Net sales 94M 67.37M 57.82M 54.27M 49.57M 93.55M 6.43B 642M 249M 3.24B 253M 247M 10.74B 116M 83.21M 71.42M 67.03M 61.22M 116M 7.94B 793M 307M 4B 312M 306M 13.26B
Net income 9.8M 7.02M 6.03M 5.66M 5.17M 9.75M 670M 66.96M 25.95M 338M 26.37M 25.8M 1.12B 13.5M 9.68M 8.3M 7.79M 7.12M 13.44M 923M 92.24M 35.75M 466M 36.33M 35.54M 1.54B
Net Debt -2.3M -1.65M -1.41M -1.33M -1.21M -2.29M -157M -15.72M -6.09M -79.32M -6.19M -6.05M -263M -7.2M -5.16M -4.43M -4.16M -3.8M -7.17M -492M -49.2M -19.07M -248M -19.37M -18.95M -822M
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
27/08/26 A$0.9050 +1.69% 41,001
26/08/26 A$0.8900 -1.93% 56,202
25/08/26 A$0.9075 -0.27% 18,384
24/08/26 A$0.9100 +1.11% 5,064
21/08/26 A$0.9000 -2.70% 20,868
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8900AUD
Average target price
1.280AUD
Spread / Average Target
+43.82%

Annual profits - Rate of surprise